This award recognises excellence in work categorized as non-commercial CSR activities, conducted by any organisation involved in any market, which shows a commitment to making a difference to communities/society, building trust in and enhancing the reputation of the pharmaceutical, medical technology and healthcare industries, whilst improving clinical outcomes and/or health economic value, whilst addressing stakeholder needs. These could include, but are not restricted to:
- The use of technology to make the use of a pharmaceutical therapy more clinically or economically effective, or both
- The use of technology and services that improve the patient/clinical experience
- Approaches to improving compliance or use of the product that led to better clinical or health economic value, or both
- Supporting healthcare systems in the delivery of service, extending accessibility and reach
- The development and delivery of services delivered leading to a better experience for stakeholders/patients/customers.
Entries are invited from any individual, team, service or organisation that has improved reputation, social responsibility and trust within the healthcare and life sciences industry. Judges will be looking for evidence of impact, sustainability and innovation.
Work conducted in the two-year period from July 2023 to June 2025 will be eligible.
